Boundless Bio, Inc. (BOLD) Stock Overview
Explore Boundless Bio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Boundless Bio, Inc. (BOLD)
Key Financials
Key Financials
Market Cap
63.6M
P/E Ratio
-0.99
EPS (TTM)
$-2.86
ROE
-0.71%
BOLD Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Boundless Bio, Inc. (NASDAQ: BOLD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Boundless Bio, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BOLD on the NASDAQ shows an RSI of 53.81, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.05 for the NASDAQ listing.
Key metrics behind Boundless Bio, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.99 and a market capitalization of 63.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BOLD on the NASDAQ.